medline.ch Neurologie Multiple Sklerose

	Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study. CNS Drugs Abbadessa G, Marastoni D, Bile F, Signoriello E, Zanghì A, Cellerino M, Cerqua R, Evangelista L, Tomassini V, Sensi S, Romano G, Risi M, Lagonigro E, Mazzone A, Gelibter S, Rispoli M, Vercellino M, Schirò G, Ragonese P, Sartori A, Malagù S, Ganino C, Mancinelli L, Lugaresi A, Lus G, Rosso F, Comar M, Merlino G, Valente M, Montepietra S, Marti A, Piscaglia MG, Surcinelli A, Tsantes E, Curti E, Fiore A, Ferraro D, Fantozzi R, Lavorgna L, D'Amico E, Gallo A, Cavalla P, Calabrese M, Inglese M, Bonavita S, Foschi M. PMID: 41604125 [PubMed - as supplied by publisher]
	A National Danish Effectiveness Study of Ocrelizumab Versus Natalizumab in Multiple Sclerosis. Eur J Neurol Maersk-Moller C, Pontieri L, Stilund MLM, Christensen JR, Storr LK, Hansen V, Schäfer J, Weglewski A, Romani KQ, Jensen HB, Illes Z, Papp V, Sejbaek T, Poulsen MB, Kant M, Torring CW, Sellebjerg F, Magyari M, DMSG Group. PMID: 41603419 [PubMed - indexed for MEDLINE]
	Association Between Early-Life Self-Medication and Multiple Sclerosis Risk: A Case-Control Study. Endocr Metab Immune Disord Drug Targets Rezaie SAS, Asgharzadeh V, Mahdavipoor B, Asgharzadeh M, Rashedi J, Alizadeh B, Oskouei SM, Siahi Y, Ozma MA. PMID: 41603186 [PubMed - as supplied by publisher]
	Multiple sclerosis and the risk of dementia: a real-world, nationwide cohort study. Front Neurol Chen TA, Li ST, Chien WC, Chung CH, Wan FJ, Yeh TC, Yeh YW, Tzeng NS. PMID: 41602975 [PubMed]
	Hybrid deep learning and feature optimization approach for early detection of multiple sclerosis. Front Hum Neurosci Anam N, S SB, Chowdhary CL. PMID: 41601605 [PubMed]
	Bioactive Phytochemicals in Experimental Models of Multiple Sclerosis: Mechanisms, Efficacy, and Translational Potential. Nutrients Guo W, Meydani SN, Wu D. PMID: 41599891 [PubMed - indexed for MEDLINE]
	Cell Therapy in Multiple Sclerosis: Clinical Advances, Limitations, and Future Perspectives from Clinical Studies-A Systematic Review. Pharmaceutics Mohamed Fathy Kamal O, Ojeda-Hernández DD, Selma-Calvo B, García-Martín M, Larriba-González MT, Martin-Blanco L, Matias-Guiu JA, Matias-Guiu J, Gomez-Pinedo U. PMID: 41599137 [PubMed]
	Reconsidering Rehabilitation and Lifestyle Approaches to Improve Quality of Life in People with Multiple Sclerosis: A Scoping Review. Medicina (Kaunas) Basalic EB, Roman NA, Minzatanu D, Manaila AI, Baseanu ICC, Miclaus RS. PMID: 41597501 [PubMed - indexed for MEDLINE]
	Therapeutic Outcomes of Fingolimod and Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis: A Real-World Study from Jordan. Medicina (Kaunas) Al Anber A, Abu Al Karsaneh O, Abuquteish D, Abdallah O, Issa MA, Sa'adeh M, Kilani D. PMID: 41597489 [PubMed - indexed for MEDLINE]
	Chronic Pain in Multiple Sclerosis: Mechanisms, Clinical Characteristics and Treatment Strategies. Int J Mol Sci Gklinos P, Christodoulou G, Pournara D, Evangelopoulos ME, Mitsikostas DD. PMID: 41596519 [PubMed - indexed for MEDLINE]
	The Role of Lipid Alteration in Multiple Sclerosis. Int J Mol Sci Damiza-Detmer A, Pawe, G. PMID: 41596461 [PubMed - indexed for MEDLINE]
	Cellular Immunotherapies for Multiple Sclerosis: Mechanistic Insights and Clinical Advances. Int J Mol Sci Kurilin V, Fisher M, Obleukhova I, Sennikov S. PMID: 41596238 [PubMed - indexed for MEDLINE]
	Integrated Biomarker-Volumetric Profiling Defines Neurodegenerative Subtypes and Predicts Neuroaxonal Injury in Multiple Sclerosis Based on Bayesian and Machine Learning Analyses. Biomedicines Ciubotaru A, Covali R, Grosu C, Alexa D, Riscanu L, Robert-Valentin B, Popa R, Sargu GD, Popa C, Filip C, Cucu LE, Vamanu A, Constantinescu V, Ignat EB. PMID: 41595578 [PubMed]
	Physical Activity as a Tool for Social Inclusion in Multiple Sclerosis: A Systematic Review of Qualitative, Quantitative, and Mixed-Methods Evidence. Sports (Basel) Marzoli F, Cardinali L, Di Pinto G, Campanella M, Colombo A, Ferrari D, Marcelli L, Silvestri F, De Giorgio A, Velardi A, Curzi D, Guidetti L. PMID: 41590967 [PubMed]
	Correlates of long-term clinical outcomes in pediatric multiple sclerosis: A 12-year study. Mult Scler Margoni M, Meani A, Pagani E, Preziosa P, Moiola L, Pozzato M, Tavazzi E, Mattioli F, Torri Clerici V, Filippi M, Rocca MA. PMID: 41588873 [PubMed - as supplied by publisher]
	Distortion in the Communication of Nonsignificant Primary Outcomes: The Spin Strategy in Multiple Sclerosis Trials. Ann Neurol Mascareñas-García M, Rivero-de-Aguilar A, Candal-Pedreira C, García G, Guerra-Tort C, Martín-Gisbert L, Rey-Brandariz J, Ríos MP, Casal-Acción B, Santiago-Pérez MI, Varela-Lema L. PMID: 41586489 [PubMed - as supplied by publisher]
	B-cell-driven relapse and anti-CD20 rescue therapy after Alemtuzumab in RRMS: case report and literature review. Front Immunol Bruno PA, Barone S, Pascarella A, Lanza PL, Tinelli E, Gambardella A, Valentino P. PMID: 41583442 [PubMed - indexed for MEDLINE]
	Prevalence of restless legs syndrome in patients with multiple sclerosis, as confirmed by sleep disorders specialists. J Neurol Aladro Y, Álvarez-Sáenz de Tejada C, Díaz-Díaz J, Pilo de la Fuente B, Martín-Ávila G, Lillo-Triguero L. PMID: 41582291 [PubMed - indexed for MEDLINE]
	Accuracy of the central vein sign in diagnosis of multiple sclerosis: a systematic review and meta-analysis. J Neurol Baiamonte L, Sera F, Bellante G, Ragonese P, Salemi G. PMID: 41582108 [PubMed - indexed for MEDLINE]
	Multiple Sclerosis in Women: Impact of Different Life Stages on Treatment Decisions. CNS Drugs McConville K, Bove R. PMID: 41580585 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 43188

Seite 1 von 2160

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung